Literature DB >> 11120765

JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome.

T A Chatila1, F Blaeser, N Ho, H M Lederman, C Voulgaropoulos, C Helms, A M Bowcock.   

Abstract

X-linked autoimmunity-allergic disregulation syndrome (XLAAD) is an X-linked recessive immunological disorder characterized by multisystem autoimmunity, particularly early-onset type 1 diabetes mellitus, associated with manifestations of severe atopy including eczema, food allergy, and eosinophilic inflammation. Consistent with the allergic phenotype, analysis of two kindreds with XLAAD revealed marked skewing of patient T lymphocytes toward the Th2 phenotype. Using a positional-candidate approach, we have identified in both kindreds mutations in JM2, a gene on Xp11.23 that encodes a fork head domain-containing protein. One point mutation at a splice junction site results in transcripts that encode a truncated protein lacking the fork head homology domain. The other mutation involves an in-frame, 3-bp deletion that is predicted to impair the function of a leucine zipper dimerization domain. Our results point to a critical role for JM2 in self tolerance and Th cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120765      PMCID: PMC387260          DOI: 10.1172/JCI11679

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome.

Authors:  P J Ferguson; S H Blanton; F T Saulsbury; M J McDuffie; V Lemahieu; J M Gastier; U Francke; S M Borowitz; J L Sutphen; T E Kelly
Journal:  Am J Med Genet       Date:  2000-02-28

2.  A transcript map of a 2-Mb BAC contig in the proximal portion of the mouse X chromosome and regional mapping of the scurfy mutation.

Authors:  G D Means; D Y Toy; P R Baum; J M Derry
Journal:  Genomics       Date:  2000-05-01       Impact factor: 5.736

3.  Congenital autoimmune diabetes mellitus.

Authors:  C M Cilio; S Bosco; C Moretti; L Farilla; F Savignoni; P Colarizi; G Multari; U Di Mario; G Bucci; F Dotta; A Bosco
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

Review 4.  Winged helix proteins.

Authors:  K S Gajiwala; S K Burley
Journal:  Curr Opin Struct Biol       Date:  2000-02       Impact factor: 6.809

Review 5.  Lineage commitment in the immune system: the T helper lymphocyte grows up.

Authors:  L H Glimcher; K M Murphy
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

Review 6.  An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.

Authors:  S E Straus; M Sneller; M J Lenardo; J M Puck; W Strober
Journal:  Ann Intern Med       Date:  1999-04-06       Impact factor: 25.391

7.  X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3.

Authors:  C L Bennett; R Yoshioka; H Kiyosawa; D F Barker; P R Fain; A O Shigeoka; P F Chance
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

8.  Cellular and molecular characterization of the scurfy mouse mutant.

Authors:  L B Clark; M W Appleby; M E Brunkow; J E Wilkinson; S F Ziegler; F Ramsdell
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

9.  An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains.

Authors: 
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

10.  A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients.

Authors:  F Cucca; J V Goy; Y Kawaguchi; L Esposito; M E Merriman; A J Wilson; H J Cordell; S C Bain; J A Todd
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

View more
  301 in total

Review 1.  New insights into the genetics of neonatal diabetes.

Authors:  Constantin Polychronakos
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Cellular therapies supplement: the role of granulocyte macrophage colony-stimulating factor and dendritic cells in regulatory T-cell homeostasis and expansion.

Authors:  Tao Zou; Atsushi Satake; Priti Ojha; Taku Kambayashi
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

3.  Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions.

Authors:  Shanru Li; Joel Weidenfeld; Edward E Morrisey
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

4.  New autoimmune genes and the pathogenesis of type 1 diabetes.

Authors:  Lars Hornum; Helle Markholst
Journal:  Curr Diab Rep       Date:  2004-04       Impact factor: 4.810

Review 5.  The role of regulatory T cells in allergy.

Authors:  Maria A Curotto de Lafaille; Juan J Lafaille
Journal:  Springer Semin Immunopathol       Date:  2003-10-22

6.  Cell-autonomous role of TGFβ and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD.

Authors:  Norifumi Sawamukai; Atsushi Satake; Amanda M Schmidt; Ian T Lamborn; Priti Ojha; Yoshiya Tanaka; Taku Kambayashi
Journal:  Blood       Date:  2012-04-10       Impact factor: 22.113

7.  A novel function of IL-2: chemokine/chemoattractant/retention receptor genes induction in Th subsets for skin and lung inflammation.

Authors:  Rahul Sharma; Sun-Sang J Sung; Felicia Gaskin; Shu Man Fu; Shyr-Te Ju
Journal:  J Autoimmun       Date:  2012-03-29       Impact factor: 7.094

8.  The Critical Role of TGF-beta1 in the Development of Induced Foxp3+ Regulatory T Cells.

Authors:  Song Guo Zheng
Journal:  Int J Clin Exp Med       Date:  2008-06-10

9.  Regulatory T cells in renal disease.

Authors:  Yuan Min Wang; Min Hu; Ya Wang; Tania Polhill; Geoff Yu Zhang; Yiping Wang; Vincent W S Lee; David C H Harris; Stephen I Alexander
Journal:  Int J Clin Exp Med       Date:  2008-08-20

10.  The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery.

Authors:  Shimon Sakaguchi
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.